Abstract:The global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated scientists to satisfy an urgent need for a rapid and accurate detection of pathogens. Traditionally, the culture-based technique is considered as the gold standard for pathogen detection, yet it has a long turnaround time due to the overnight culturing and pathogen isolation. Alternatively, nucleic acid amplification tests provide a relatively shorter turnaround time to identify whether pathogens exist in individuals with high sensitivity and high specificity. In most cases, nucleic acid amplification tests undergo three steps: sample preparation, nucleic acid amplification, and signal transduction. Despite the explosive advancement in nucleic acid amplification and signal transduction technologies, the complex and labor-intensive sample preparation steps remain a bottleneck to create a transformative integrated point-of-care (POC) molecular diagnostic device. Researchers have attempted to simplify and integrate the sample preparations for nucleic acid-based molecular diagnostic devices with innovative progress in integration strategies, engineered materials, reagent storages, and fluid actuation. Therefore, understanding the know-how and obtaining truthful knowledge of existing integrated POC molecular diagnostic devices comprising sample preparations, nucleic acid amplification, and signal transduction can generate innovative solutions to achieve personalized precision medicine and improve global health.In this Account, we discuss the challenges of automated sample preparation solutions integrated with nucleic acid amplification and signal transduction for rapid and precise home diagnostics. Blood, nasal swab, saliva, urine, and stool are emphasized as the most commonly used clinical samples for integrated POC molecular diagnostics of infectious diseases. Even though these five types of samples possess relatively correlated biomarkers due to the human body's circulatory system, each shows unique properties and exclusive advantages for molecular diagnostics in specific situations, which are included in this Account. We examine different integrated POC devices for sample preparation, which includes pathogen isolation and enrichment from the crude sample and nucleic acid purification from isolated pathogens. We present the promising on-chip integration approaches for nucleic acid amplification. We also investigate the on-chip integration methods for reagent storage, which is crucial to simplify the manual operation for end-users. Finally, we present several integrated POC molecular diagnostic devices for infectious diseases. The integrated sample preparation and nucleic acid amplification approach reviewed here can potentially impact the next generation of POC molecular home diagnostic chips, which will significantly impact public health, emergency medicine, and global biosecurity.

Microfluidic-assisted integrated nucleic acid test strips for POCT

Lateral flow–based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use

Nanoparticle-Assisted Signal-Enhancement Technique for Lateral Flow Immunoassays

Recent advancements in nucleic acid detection with microfluidic chip for molecular diagnostics

Recent advances in nucleic acid analysis and detection with microfluidic and nanofluidics

All-in-one microfluidic chip for 30-min quantitative point-of-care-testing of nucleic acids

Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example

Integrated Microfluidic Systems with Sample Preparation and Nucleic Acid Amplification.

Latest Improvement of Lateral Flow Assay in Detecting Nucleic Acid and Food Contaminant

Development of Integrated Systems for On-Site Infection Detection

Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT)

Amplification-Free Nucleic Acid Testing with a Fluorescence One-Step-Branched DNA-Based Lateral Flow Assay (FOB-LFA)

Fully Integrated Microfluidic Devices for Qualitative, Quantitative and Digital Nucleic Acids Testing at Point of Care

An Integrated Lateral Flow Assay for Effective DNA Amplification and Detection at the Point of Care.

Integrated Point-of-Care Molecular Diagnostic Devices for Infectious Diseases

The Application of Lateral Flow Immunoassay in Point of Care Testing: A Review

UbiNAAT: a multiplexed point-of-care nucleic acid diagnostic platform for rapid at-home pathogen detection

Trimodal Multiplexed Lateral Flow Test Strips Assisted with a Portable Microfluidic Centrifugation Device

Prospects of Microfluidic Technology in Nucleic Acid Detection Approaches

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology

Rapid on-site nucleic acid testing: On-chip sample preparation, amplification, and detection, and their integration into all-in-one systems